 SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 PRNewswire -- IDEAYA Biosciences, Inc. Nasdaq:IDYA, an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, today announced it has submitted an Investigational New Drug IND... 